AbbVie, Astellas, Eikon, Merck, Moderna,
Roche, and more share new ideas to advance drug development
PLEASANTON, Calif., Aug. 13,
2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today
announced that industry leaders from AbbVie, Astellas, Eikon
Therapeutics, Merck & Co., Moderna, and Roche will keynote at
the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept.
9-10. Professionals across life sciences will come together
to discuss how connected systems across clinical, regulatory,
safety, and quality can move the industry forward for the benefit
of patients.
Veeva R&D and Quality Summit is one of the largest life
sciences events, drawing more than 2,000 executives to network and
learn across more than 100 sessions. Veeva CEO Peter Gassner headlines the opening keynote,
sharing innovations and examples of how connected data and systems
can significantly streamline drug development and accelerate
product time to market. Additional featured keynotes and sessions
include:
- AbbVie and Merck discuss the impact of
pharmacovigilance transformation on operational visibility and
end-to-end efficiency.
- Astellas explains its holistic approach to driving
end-to-end clinical processes for increased speed and
transparency.
- Eikon Therapeutics highlights the benefits of
establishing a foundation for scalable and efficient development
from clinical trial to product launch.
- Neurogene and Verve Therapeutics discuss
modernizing quality control with simplified processes and
digital-first quality execution.
- Sanofi showcases leveraging AI-powered translation for
faster submission timelines.
- UCB shares its enterprise eCOA journey to accelerate
delivery and standardize patient data capture.
"Veeva is committed to customer success, delivering integrated
software, data, and services that can advance innovation for
patients in need," said Jim Reilly,
vice president of Veeva Development Cloud strategy. "Veeva R&D
and Quality Summit brings the industry together to share learnings,
fresh ideas, and new strategies to improve collaboration and
accelerate the delivery of novel products."
The event is open exclusively to life sciences professionals.
Register and stay up to date on the agenda
at veeva.com/Summit.
Additional Information
Register for Veeva R&D and
Quality Summit: veeva.com/Summit/register
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/life-sciences-community-advances-toward-next-phase-of-innovation-at-veeva-rd-and-quality-summit-302220776.html
SOURCE Veeva Systems